Bupropion as an add-on therapy in depressed bipolar disorder type i patients with comorbid cocaine dependence

Clinical Neuropharmacology

Volumn 37, Issue 1, 2014, Pages 17-21

  Sepede, Gianna ^a   Di Lorio, Giuseppe ^a,b,c   Lupi, Matteo ^a,c   Sarchione, Fabiola ^a   Acciavatti, Tiziano ^a   Fiori, Federica ^a,c   Santacroce, Rita ^a   Martinotti, Giovanni ^a   Gambi, Francesco ^a   Di Giannantonio, Massimo ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b National Health Trust   (Italy)

^c Psychiatric Rehabilitation Clinic villa Jolanda   (Italy)

Author keywords

add on strategies; bipolar disorder; bupropion; cocaine dependence disorder

Indexed keywords

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BUPROPION; COCAINE-RELATED DISORDERS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; VALPROIC ACID; YOUNG ADULT;

EID: 84895073285     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0000000000000011     Document Type: Article

References (41)

1. Schaffer A, Cairney J, Veldhuizen S, et al. A population-based analysis of distinguishers of bipolar disorder from major depressive disorder. J Affect Disord 2010;125:103-110
2. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001;3(4):181-188. (Pubitemid 32842743)
3. Grant B, Stinson F, Hasin D, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005;66:1205-1215. (Pubitemid 41546498)
4. Regier D, Farmer M, Rae D, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264(19):2511-2518.
5. Strakowski SM, DelBello MP. The co-occurrence of bipolar and substance use disorders. Clin Psychol Rev 2000;20(2):191-206. (Pubitemid 30100432)
6. Tondo L, Vázquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand 2010;121(6):404-414.
7. Martinotti G, Sepede G, Signorelli M, et al. Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review. Exp Opin Pharmacother 2013;14(8):1065-1075.
8. Vieta E, Owen R, Baudelet C, et al. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study. Curr Med Res Opin 2010;26(6):1485-1496.
9. Vieta E, Locklear J, Günther O, et al. Treatment options for bipolar depression: a systematic review of randomized, controlled trials. J Clin Psychopharmacol 2010;30(5):579-590.
10. Zarate CAJr, Tohen M. Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. Am J Psychiatry 2004;161:169-171. (Pubitemid 38419326)
11. Srivastava S, Ketter TA. Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects. Clin Ther 2011;33(12):B40-B48.
12. Martinotti G, Andreoli S, Di Nicola M, et al. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol 2008;23(5):417-424
13. Connolly KR, Thase ME. The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord 2011;13(4). pii: PCC.10r01097. doi: 10.4088/PCC.10r01097.
14. Marcus R, Khan A, Rollin L, et al. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disord 2011;13(2):133-144.
15. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013;15(1):1-44.
16. Fountoulakis KN, Vieta E. Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review. Ann Gen Psychiatry 2009;8:16.
17. Goldstein BI, Bukstein OG. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention. J Clin Psychiatry 2010;71:348-358.
18. Swann AC. The strong relationship between bipolar and substance-use disorder. Ann N Y Acad Sci 2010;1187:276-93.
19. Brown ES, Sunderajan P, Hu LT, et al. A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence. Neuropsychopharmacology 2012;37(11):2347-2354.
20. Brown ES, Perantie DC, Dhanani N, et al. Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. J Affect Disord 2006;93(1-3):219-222. (Pubitemid 43816049)
21. Kemp DE, Gao K, Ganocy SJ, et al. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. J Clin Psychiatry 2009; 70(1):113-121.
22. Nejtek VA, Avila M, Chen LA, et al. Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. J Clin Psychiatry 2008;69(8):1257-1266.
23. Cerullo and Strakowski. The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy 2007;2:29.
24. Sarchiapone M, Carli V, Di Giannantonio M, et al. Risk factors for attempting suicide in prisoners. Suicide Life-Threatening Behav 2009; 39(3):343-350.
25. Brady KT, Sonne SC, Anton R, et al. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry 1995;56(3):118-121.
26. Salloum IM, Douaihy A, Cornelius JR, et al. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study. Addict Behav 2007;32(2):410-415. (Pubitemid 44918222)
27. Beaulieu S, Saury S, Sareen J, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry 2012;24(1):38-55.
28. Brunetti M, Di Tizio L, Dezi S, et al. Aripiprazole, alcohol and substance abuse: a review. Eur Rev Med Pharmacol Sci 2012;16(10): 1346-1354.
29. Martinotti G, Di Nicola M, Di Giannantonio M, et al. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs naltrexone. J Psychopharmacol 2009;23(2):123-129.
30. Brown ES, Jeffress J, Liggin JD, et al. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. J Clin Psychiatry 2005;66(6): 756-760. (Pubitemid 40942423)
31. Castells X, Casas M, Pérez-Mañá C, et al. Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev 2010;(2): CD007380.
32. Margolin A, Kosten TR, Avants SK, et al. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend 1995;40(2):125-131. (Pubitemid 26011975)
33. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56.
34. Skinner HA. The drug abuse screening test. Addict Behav 1982;7(4): 363-371. (Pubitemid 13162181)
35. Young RC, Biggs JT, Ziegler VE et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435. (Pubitemid 9006756)
36. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006;163(2): 232-239. (Pubitemid 44480842)
37. Frank E, Boland E, Novick DM, et al. Association between illicit drug and alcohol use and first manic episode. Pharmacol Biochem Behav 2007;86(2):395-400. (Pubitemid 46282056)
38. Strakowski S, DelBello M, Fleck D, et al. Effect of co-occuring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry 2005;62:851-858. (Pubitemid 41126879)
39. Poling J, Oliveto A, Petry N, et al. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry 2006;63(2): 219-228. (Pubitemid 43213884)
40. Volkow ND, Fowler JS, Wang GJ, et al. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009;56(Suppl 1):3-8.
41. Learned-Coughlin SM, BergströmM, Savitcheva I, et al. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 2003;54(8):800-805. (Pubitemid 37205131)